Index of /data/fantom5/datafiles/phase2.5/basic/human.cell_line.CAGEScan
Name
Last modified
Size
Description
Parent Directory
-
00_human.cell_line.CAGEScan.hg19.assay_sdrf.txt
2017-01-26 14:13
17K
acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
297M
acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
288M
acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.bam
2017-01-26 17:55
389M
acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.bam.bai
2017-01-26 17:55
5.0M
acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
886K
acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
81M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
150M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
151M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.bam
2017-01-26 17:55
191M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.7M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
436K
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
30M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
151M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
146M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.bam
2017-01-26 17:55
176M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.7M
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
427K
cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
27M
chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
168M
chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
164M
chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.bam
2017-01-26 17:56
225M
chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.1M
chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
536K
chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
47M
epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
177M
epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
173M
epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.bam
2017-01-26 17:56
209M
epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.9M
epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
676K
epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
41M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
143M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
141M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.bam
2017-01-26 17:56
195M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.7M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
379K
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
39M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
118M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
117M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.bam
2017-01-26 17:56
150M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.7M
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
323K
extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
27M
glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
260M
glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
256M
glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.bam
2017-01-26 17:56
303M
glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.bam.bai
2017-01-26 17:54
4.4M
glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
806K
glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
64M
malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
323M
malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
305M
malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.bam
2017-01-26 17:56
403M
malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.bam.bai
2017-01-26 17:55
5.2M
malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
863K
malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
79M
maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
291M
maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
280M
maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.bam
2017-01-26 17:56
401M
maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.bam.bai
2017-01-26 17:55
5.3M
maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
697K
maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
81M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
157M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
156M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.bam
2017-01-26 17:54
211M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.bam.bai
2017-01-26 17:56
4.2M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:55
507K
myeloma%20cell%20line%3aPCM6%2c%20tech_rep1.NCig10067.10474-106I6.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
41M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
144M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
142M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.bam
2017-01-26 17:54
181M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.bam.bai
2017-01-26 17:56
4.2M
myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:55
478K
myeloma%20cell%20line%3aPCM6%2c%20tech_rep2.NCig10131.10474-106I6.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
34M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
164M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
163M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.bam
2017-01-26 17:56
256M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.3M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
389K
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
54M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
190M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
181M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.bam
2017-01-26 17:56
288M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.5M
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
435K
neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
63M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
154M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
154M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.bam
2017-01-26 17:56
203M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.4M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
506K
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
39M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
171M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
166M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.bam
2017-01-26 17:56
215M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.7M
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
533K
osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
41M
renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
230M
renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
222M
renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.bam
2017-01-26 17:56
260M
renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.5M
renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
687K
renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
52M
schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
249M
schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
243M
schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.bam
2017-01-26 17:56
318M
schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.2M
schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
862K
schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:54
63M
signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
272M
signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
264M
signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.bam
2017-01-26 17:56
295M
signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.6M
signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
698K
signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
55M
splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
157M
splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
154M
splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.bam
2017-01-26 17:55
220M
splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.9M
splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
431K
splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
40M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:54
143M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:54
141M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.bam
2017-01-26 17:56
190M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.bam.bai
2017-01-26 17:55
4.0M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:54
371K
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
38M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.3prime.fq.gz
2017-01-26 17:55
121M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.5prime.fq.gz
2017-01-26 17:55
121M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.bam
2017-01-26 17:55
152M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.bam.bai
2017-01-26 17:55
3.9M
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.clusters.bed.gz
2017-01-26 17:55
315K
synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.pairs.bed.gz
2017-01-26 17:55
26M